Table 2.
Clinical details of SHI patients (CSF group)
| Parameters | CSF samples (n = 10) |
|---|---|
| Ageb | 32.7 ± 14.9 |
| Sexa | |
| Male | 10 (100) |
| Female | 0 |
| Mode of injurya | |
| RTA | 6 (60) |
| Fall | 3 (30) |
| Miscellaneous | 1 (10) |
| ICU Length of stay | 10 (1–42) |
| Hospital length of stayb | 24.2 ± 9.6 |
| Systolic BPb | 114.12 ± 36.3 |
| Time elapsed from injury to sampling (h) | 8 (5–11) |
| Red blood cells cells/cumm | 110 (23-full field) |
| White blood cells (0–5 MNC/cumm) | 330 (0–800) |
| Glucose (40–70-mg/dl) | 61 (9–98) |
| Protein (mg/dl) | 109.5 (56–865) |
| Emergency surgery | |
| Yes | 7 (70) |
| No | 3 (30) |
| Sepsis | |
| Yes | 4 (40) |
| No | 6 (60) |
| Outcomea | |
| Alive | 6 (60) |
| Dead | 4 (40) |
| Glasgow outcome score (GOS)a | |
| Good recovery | 4 (40) |
| Moderate disability | 0 |
| Severe disability | 1 (10) |
| Persistent vegetative | 1 (10) |
| Death | 4 (40) |
aFrequency (%)
bMean ± SD